Defense World
25 Apr 2026, 06:19 UTC · 22w ago
Telomir Pharmaceuticals (NASDAQ:TELO) Trading 1.4% Higher – Here’s What Happened
Verdict
Headline leans bullish. We score TELO +0.20.
Score confirms the headline.
- Headline says
Leans bullish
From its wording — no explicit rating
- Expected · TELO
+0.20slightly bullish




